| scholarly article | Q13442814 |
| P2093 | author name string | Shahram Nazarian | |
| Seyed Latif Mousavi Gargari | |||
| Nafiseh Noroozi | |||
| Samaneh Sarvary | |||
| Razieh Rezaei Adriani | |||
| P2860 | cites work | Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process | Q84253443 |
| Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention | Q24530558 | ||
| Bacterial outer membrane vesicles and vaccine applications | Q24568229 | ||
| Biological functions and biogenesis of secreted bacterial outer membrane vesicles | Q24599020 | ||
| Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria | Q26827724 | ||
| Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility | Q30496874 | ||
| Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins | Q33963134 | ||
| Immunogenicity of a fusion protein comprising coli surface antigen 3 and labile B subunit of enterotoxigenic Escherichia coli | Q34475844 | ||
| An Adult Mouse Model of Vibrio cholerae-induced Diarrhea for Studying Pathogenesis and Potential Therapy of Cholera | Q34798092 | ||
| Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis | Q34983894 | ||
| Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers | Q35877982 | ||
| A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles | Q35935738 | ||
| Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea | Q36166749 | ||
| Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea | Q36183417 | ||
| The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection | Q36593894 | ||
| Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease | Q36708480 | ||
| Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. | Q36898523 | ||
| Stress-induced outer membrane vesicle production by Pseudomonas aeruginosa | Q36970542 | ||
| Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria | Q38234687 | ||
| Delivery strategies to enhance oral vaccination against enteric infections. | Q38393940 | ||
| Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies | Q38461061 | ||
| Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli. | Q38955024 | ||
| Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study | Q41637482 | ||
| Efficacy of thiolated eudragit microspheres as an oral vaccine delivery system to induce mucosal immunity against enterotoxigenic Escherichia coli in mice | Q43231284 | ||
| Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice | Q43623067 | ||
| An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt | Q46265378 | ||
| Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). | Q46295795 | ||
| Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen | Q46564196 | ||
| An in silico chimeric multi subunit vaccine targeting virulence factors of enterotoxigenic Escherichia coli (ETEC) with its bacterial inbuilt adjuvant. | Q46898616 | ||
| A PLGA-encapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coli | Q47881939 | ||
| Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review. | Q50086428 | ||
| Prevalent phenotypic and genotypic profile of enterotoxigenic Escherichia coli among Iranian children. | Q51459526 | ||
| A CssA, CssB and LTB chimeric protein induces protection against Enterotoxigenic Escherichia coli. | Q53133446 | ||
| Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens | Q73371849 | ||
| Oral vaccines: new needs, new possibilities | Q80348505 | ||
| Meningococcal vaccines | Q81137294 | ||
| P433 | issue | 3 | |
| P921 | main subject | Escherichia coli | Q25419 |
| enterotoxigenic Escherichia coli | Q265214 | ||
| P304 | page(s) | 284-291 | |
| P577 | publication date | 2018-03-01 | |
| P1433 | published in | Iranian Journal of Basic Medical Sciences | Q20850646 |
| P1476 | title | Immunogenicity of enterotoxigenic Escherichia coli outer membrane vesicles encapsulated in chitosan nanoparticles. | |
| P478 | volume | 21 |
| Q55386075 | An LTB-entrapped protein in PLGA nanoparticles preserves against enterotoxin of enterotoxigenic Escherichia coli. | cites work | P2860 |
Search more.